Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer, The Lancet Infectious Diseases, vol.9, issue.11, pp.699-710, 2009. ,
DOI : 10.1016/S1473-3099(09)70234-8
Mycolactones and Mycobacterium ulcerans disease, The Lancet, vol.362, issue.9389, pp.1062-1064, 2003. ,
DOI : 10.1016/S0140-6736(03)14417-0
Buruli ulcer: emerging from obscurity, The Lancet, vol.367, issue.9525, pp.1849-1858, 2006. ,
DOI : 10.1016/S0140-6736(06)68807-7
Buruli Ulcer in Ghana: Results of a National Case Search, Emerging Infectious Diseases, vol.8, issue.2, pp.167-170, 2002. ,
DOI : 10.3201/eid0802.010119
Cutaneous leishmaniasis in Pakistan, Dermatol Online J, vol.11, issue.4, 2005. ,
Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease, Appl Environ Microbiol, vol.63, pp.4135-4138, 1997. ,
Disease (Buruli Ulcer) Following a Human Bite, Clinical Infectious Diseases, vol.36, issue.5, pp.67-68, 2003. ,
DOI : 10.1086/367660
Ecology and Transmission of Buruli Ulcer Disease: A Systematic Review, PLoS Neglected Tropical Diseases, vol.30, issue.1, p.911, 2010. ,
DOI : 10.1371/journal.pntd.0000911.s001
Infection, Emerging Infectious Diseases, vol.9, issue.6, pp.651-656, 2003. ,
DOI : 10.3201/eid0906.020485
Mycobacterium ulcerans infection, The Lancet, vol.337, issue.8733, 1991. ,
DOI : 10.1016/0140-6736(91)90791-M
The pathology of mycobacterium ulcerans infection, Pathology, vol.17, issue.4, pp.594-600, 1985. ,
DOI : 10.3109/00313028509084759
Systemic suppression of interferon-?? responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans, Journal of Leukocyte Biology, vol.79, issue.6, pp.1150-1156, 2006. ,
DOI : 10.1189/jlb.1005581
Immunosuppressive Signature of Cutaneous Mycobacterium ulcerans Infection in the Peripheral Blood of Patients with Buruli Ulcer Disease, J Infect Dis, 2009. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01402286
Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence, Science, vol.283, issue.5403, pp.854-857, 1999. ,
DOI : 10.1126/science.283.5403.854
Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria, Natural Product Reports, vol.45, issue.3, pp.447-454, 2008. ,
DOI : 10.1039/b803101k
toxin mycolactone, The Journal of Experimental Medicine, vol.22, issue.6, pp.1395-1403, 2007. ,
DOI : 10.1016/0022-1759(94)90236-4
URL : https://hal.archives-ouvertes.fr/pasteur-01402321
Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin, Cellular Microbiology, vol.34, issue.8, pp.1187-1196, 2005. ,
DOI : 10.1016/S0140-6736(99)01156-3
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans, Nature Reviews Microbiology, vol.4, issue.1, pp.50-60, 2009. ,
DOI : 10.1093/molbev/msm092
Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression, Proceedings of the National Academy of Sciences, vol.108, issue.31, pp.12833-12838, 2011. ,
DOI : 10.1073/pnas.1016496108
URL : https://hal.archives-ouvertes.fr/pasteur-00738806
The inhibitory action of Mycobacterium ulcerans soluble factor on monocyte/T cell cytokine production and NF-kappa B function, J Immunol, vol.163, pp.3928-3935, 1999. ,
The Interaction between N-WASP and the Arp2/3 Complex Links Cdc42-Dependent Signals to Actin Assembly, Cell, vol.97, issue.2, pp.221-231, 1999. ,
DOI : 10.1016/S0092-8674(00)80732-1
WASP: a key immunological multitasker, Nature Reviews Immunology, vol.37, issue.3, pp.182-192, 2010. ,
DOI : 10.1038/nri2724
N-WASP regulates the epithelial junctional actin cytoskeleton through a non-canonical post-nucleation pathway, Nature Cell Biology, vol.104, issue.8, pp.934-943, 2011. ,
DOI : 10.1038/ncb2290
N-WASP is a novel regulator of hair-follicle cycling that controls antiproliferative TGF?? pathways, Journal of Cell Science, vol.123, issue.1, pp.128-140, 2010. ,
DOI : 10.1242/jcs.053835
Neural Wiskott-Aldrich syndrome protein modulates Wnt signaling and is required for hair follicle cycling in mice, Journal of Clinical Investigation, vol.120, issue.2, pp.446-456, 2010. ,
DOI : 10.1172/JCI36478DS1
Polarity proteins in migration and invasion, Oncogene, vol.27, issue.55, pp.6970-6980, 2008. ,
DOI : 10.1038/ncb1603
Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation, Nature Structural & Molecular Biology, vol.8, issue.8, pp.747-755, 2004. ,
DOI : 10.1006/jmbi.1997.1044
The evolution of the lesion in cutaneous leishmaniasis, The Journal of Pathology, vol.73, issue.1, pp.83-96, 1983. ,
DOI : 10.1002/path.1711410109
Leishmaniasis, Journal of the American Academy of Dermatology, vol.34, issue.2, pp.257-272, 1996. ,
DOI : 10.1016/S0190-9622(96)80121-6
Immunobiology of leishmaniasis, Indian J Exp Biol, vol.47, pp.412-423, 2009. ,
Successful Treatment of Cutaneous Leishmaniasis Using Systemic Interferon-Gamma, Dermatology, vol.192, issue.1, pp.56-60, 1996. ,
DOI : 10.1159/000246316
Cutaneous leishmaniasis mimicking inflammatory and neoplastic processes: a clinical, histopathological and molecular study of 57 cases, Journal of Cutaneous Pathology, vol.43, issue.2 Pt 1, pp.251-262, 2012. ,
DOI : 10.1111/j.1600-0560.2011.01844.x
Systemic FasL and TRAIL Neutralisation Reduce Leishmaniasis Induced Skin Ulceration, PLoS Neglected Tropical Diseases, vol.106, issue.10, p.844, 2010. ,
DOI : 10.1371/journal.pntd.0000844.s003
URL : http://doi.org/10.1371/journal.pntd.0000844
FasL and TRAIL signaling in the skin during cutaneous leishmaniasis - implications for tissue immunopathology and infectious control, Frontiers in Immunology, vol.3, p.163, 2012. ,
DOI : 10.3389/fimmu.2012.00163
Lesion Size Correlates with Leishmania Antigen-Stimulated TNF-Levels in Human Cutaneous Leishmaniasis, American Journal of Tropical Medicine and Hygiene, vol.85, issue.1, pp.70-73, 2011. ,
DOI : 10.4269/ajtmh.2011.10-0680
Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans, Microbial Pathogenesis, vol.34, issue.2, pp.91-101, 2003. ,
DOI : 10.1016/S0882-4010(02)00210-3
A Mycobacterium ulcerans Toxin, Mycolactone, Causes Apoptosis in Guinea Pig Ulcers and Tissue Culture Cells, Infection and Immunity, vol.68, issue.2, pp.877-883, 2000. ,
DOI : 10.1128/IAI.68.2.877-883.2000
Prospects for vaccine development against Buruli disease, Expert Review of Vaccines, vol.2, issue.4, pp.561-569, 2003. ,
DOI : 10.1586/14760584.2.4.561
Orally Administered Combined Regimens for Treatment of Mycobacterium ulcerans Infection in Mice, Antimicrobial Agents and Chemotherapy, vol.51, issue.10, pp.3737-3739, 2007. ,
DOI : 10.1128/AAC.00730-07
Neural Wiskott-Aldrich Syndrome Protein (N-WASP)-mediated p120-Catenin Interaction with Arp2-Actin Complex Stabilizes Endothelial Adherens Junctions, Journal of Biological Chemistry, vol.288, issue.6 ,
DOI : 10.1074/jbc.M112.440396
Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection, Clinical Infectious Diseases, vol.54, issue.4, pp.519-526, 2012. ,
DOI : 10.1093/cid/cir856
Corticosteroid Use for Paradoxical Reactions during Antibiotic Treatment for Mycobacterium ulcerans, PLoS Neglected Tropical Diseases, vol.6, issue.9, p.1767, 2012. ,
DOI : 10.1371/journal.pntd.0001767.t001
Steroids control paradoxical worsening of Mycobacterium ulcerans infection following initiation of antibiotic therapy, The Medical Journal of Australia, vol.198, issue.8, pp.443-444, 2013. ,
DOI : 10.5694/mja12.11559